scholarly article | Q13442814 |
P356 | DOI | 10.1038/NM0303-261 |
P8608 | Fatcat ID | release_tkgicjemzvdwvjufdhz6wienre |
P698 | PubMed publication ID | 12612569 |
P2093 | author name string | Chris Boshoff | |
P2860 | cites work | Aids-related malignancies | Q22251046 |
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. | Q34531461 | ||
Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling | Q40690911 | ||
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator | Q42833351 | ||
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo | Q46725222 | ||
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes | Q78860218 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 261-262 | |
P577 | publication date | 2003-03-01 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | Kaposi virus scores cancer coup | |
P478 | volume | 9 |
Q39675686 | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores |
Q36086302 | Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis |
Q94593890 | Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers |
Q39794624 | Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. |
Q40267803 | Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro |
Q35642220 | KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development. |
Q35127940 | Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis |
Q36423989 | Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor |
Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
Q36978654 | Phosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt |
Q31083547 | Pyogenic granuloma: an unrecognized cause of gastrointestinal bleeding |
Q35124429 | Structure and function of latency-associated nuclear antigen |
Search more.